Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr21.39 Mil
% of Total Estimate Gain
48.22%

MFS Low Volatility Global Equity Fund's Novo Nordisk AS Holding Summary

As of 2025-02-28, MFS SERIES TRUST I held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and MFS SERIES TRUST I now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2022Q1. And since then MFS Low Volatility Global Equity Fund has made 5 purchases of OCSE:NOVO B, at an average price of kr345.12, for a total of 128,520.00 shares. In addition, there have been 8 sales at an average price of kr511.55 for 128,520.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr441.20, MFS Low Volatility Global Equity Fund's estimated gain on his OCSE:NOVO B holdings is kr21.39 Mil, reflecting a 48.22% gain to date.

MFS Low Volatility Global Equity Fund OCSE:NOVO B (kr441.20) Holding Chart

MFS Low Volatility Global Equity Fund OCSE:NOVO B (kr441.20) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1